Profil
John Le Gall is currently Chief Medical Officer at Imugene Ltd., starting in 2026.
Formerly, Dr. Le Gall was Vice President & Head-Clinical Development at Allogene Therapeutics, Inc. from 2023 to 2026.
Education includes an MBA and a doctorate from The Trustees of Columbia University in The City of New York.
Aktive Positionen von John Le Gall
| Unternehmen | Position | Beginn |
|---|---|---|
| IMUGENE LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 07.10.2026 |
Ehemalige bekannte Positionen von John Le Gall
| Unternehmen | Position | Ende |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
Ausbildung von John Le Gall
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
















